A force of nature
During the last decade sustainability has risen to the very summit of company agendas. Mewburn Ellis’s Joe Newcombe looks out to pharma’s cleaner, greener horizon
Read More
Search Results for: Joe Newcombe
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
